{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T23:24:52Z","timestamp":1789428292574,"version":"build-2803163510"},"reference-count":13,"publisher":"BMJ","issue":"3","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Pract Neurol"],"accepted":{"date-parts":[[2020,2,22]]},"published-print":{"date-parts":[[2020,5]]},"abstract":"<jats:p>Immune checkpoint inhibitors have transformed the treatment of advanced malignancy, while increasing the risk of immune-related adverse events. A 56-year-old woman who had received nivolumab for stage 4 renal cell carcinoma subsequently developed altered behaviour, memory deficits and worsening of previously stable epilepsy. MR scan of the brain showed bilateral FLAIR (fluid-attenuated inversion recovery) hyperintensity of the mesial temporal lobes, and there were anti-Ma2 antibodies in both serum and cerebrospinal fluid. She was treated with corticosteroids but developed further clinical relapses requiring immunoglobulin and rituximab. The immune-related adverse events relating to immune checkpoint inhibitors are an emerging challenge for the neurologist. Some cases are refractory and require serial immunosuppression.<\/jats:p>","DOI":"10.1136\/practneurol-2019-002464","type":"journal-article","created":{"date-parts":[[2020,4,17]],"date-time":"2020-04-17T17:16:45Z","timestamp":1587143805000},"page":"256-259","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":20,"title":["Autoimmune encephalitis associated with Ma2 antibodies and immune checkpoint inhibitor therapy"],"prefix":"10.1136","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8381-7531","authenticated-orcid":false,"given":"Shane","family":"Lyons","sequence":"first","affiliation":[{"name":"Neurology Department, University Hospital Galway, Galway, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronan","family":"Joyce","sequence":"additional","affiliation":[{"name":"Neurology Department, University Hospital Galway, Galway, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Moynagh","sequence":"additional","affiliation":[{"name":"Neurology Department, University Hospital Galway, Galway, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"O\"Donnell","sequence":"additional","affiliation":[{"name":"Neurology Department, University Hospital Galway, Galway, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silive","family":"Blazkova","sequence":"additional","affiliation":[{"name":"Oncology Department, University Hospital Galway, Galway, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy J","family":"Counihan","sequence":"additional","affiliation":[{"name":"Neurology Department, University Hospital Galway, Galway, Ireland"},{"name":"National University of Ireland Galway, Galway, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,4,17]]},"reference":[{"key":"2025090410305338000_20.3.256.1","doi-asserted-by":"crossref","DOI":"10.1177\/1756286418799864","article-title":"Neurological complications of immune checkpoint inhibitors: what happens when you \u2018take the brakes off\u2019 the immune system","volume":"11","author":"Dalakas","year":"2018","journal-title":"Ther Adv Neurol Disord"},{"key":"2025090410305338000_20.3.256.2","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s11060-018-2752-5","article-title":"Neurologic complications of immune checkpoint inhibitors","volume":"137","author":"Fellner","year":"2018","journal-title":"J Neurooncol"},{"key":"2025090410305338000_20.3.256.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2016.12.001"},{"key":"2025090410305338000_20.3.256.4","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.3390\/jcm8111777","article-title":"Neurological immune related adverse events associated with nivolumab, ipilimumab, and pembrolizumab Therapy\u2014Review of the literature and future outlook","volume":"8","author":"M\u00f6hn","year":"2019","journal-title":"JCM"},{"key":"2025090410305338000_20.3.256.5","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/5190794"},{"key":"2025090410305338000_20.3.256.6","doi-asserted-by":"crossref","unstructured":"Dalmau J , Graus F , Villarejo A . Clinical analysis of anti-Ma2-associated encephalitis. Brain ;127:1831\u201344.doi:10.1093\/brain\/awh203","DOI":"10.1093\/brain\/awh203"},{"key":"2025090410305338000_20.3.256.7","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000604"},{"key":"2025090410305338000_20.3.256.8","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000557","article-title":"Atypical presentation of anti-Ma2-associated encephalitis with choreiform movement","volume":"6","author":"Lamby","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2025090410305338000_20.3.256.9","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jns.2015.01.028","article-title":"Anti-Ma-associated encephalomyeloradiculopathy in a patient with pleural mesothelioma","volume":"350","author":"Vogrig","year":"2015","journal-title":"J Neurol Sci"},{"key":"2025090410305338000_20.3.256.10","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2011.56"},{"key":"2025090410305338000_20.3.256.11","doi-asserted-by":"crossref","DOI":"10.1186\/s13256-018-1786-9","article-title":"Nivolumab induced encephalopathy in a man with metastatic renal cell cancer: a case report","volume":"12","author":"Kopeck\u00fd","year":"2018","journal-title":"J Med Case Rep"},{"key":"2025090410305338000_20.3.256.12","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/acn3.547","article-title":"Seronegative antibody-mediated neurology after immune checkpoint inhibitors","volume":"5","author":"Wilson","year":"2018","journal-title":"Ann Clin Transl Neurol"},{"key":"2025090410305338000_20.3.256.13","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.77.6385"}],"container-title":["Practical Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/practneurol-2019-002464","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T17:31:04Z","timestamp":1757007064000},"score":1,"resource":{"primary":{"URL":"https:\/\/pn.bmj.com\/lookup\/doi\/10.1136\/practneurol-2019-002464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,17]]},"references-count":13,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,6,2]]},"published-print":{"date-parts":[[2020,5]]}},"alternative-id":["10.1136\/practneurol-2019-002464"],"URL":"https:\/\/doi.org\/10.1136\/practneurol-2019-002464","relation":{},"ISSN":["1474-7758","1474-7766"],"issn-type":[{"value":"1474-7758","type":"print"},{"value":"1474-7766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,17]]}}}